Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon E Frey

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|August 8, 2015
Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activityAlla Kachko, Sharon E Frey, Lev Sirota, et al.
The Journal of Infectious Diseases|September 20, 2005
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functionsGetahun Abate, Joy Eslick, Frances K Newman, et al.
Vaccine|December 17, 2008
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adultsSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
The Journal of Infectious Diseases|January 28, 2004
Dose-dependent neutralizing-antibody responses to vacciniaRobert B Belshe, Frances K Newman, Sharon E Frey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2013
CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humansLiusong Yin, J Mauricio Calvo-Calle, John Cruz, et al.
Vaccine|February 7, 2022
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderlyGeoffrey J Gorse, Stephen Grimes, Helen Buck, et al.
The Journal of Infectious Diseases|August 4, 2010
Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteinsRanjit Ray, Keith Meyer, Arup Banerjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Evidence for probable sexual transmission of the hepatitis g virusSharon E Frey, Sharon M Homan, Marcia Sokol-Anderson, et al.
Vaccine|February 7, 2022
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery systemGeoffrey J Gorse, Stephen Grimes, Helen Buck, et al.
Vaccine|November 9, 2010
VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response aloneLeonard Moise, R Mark Buller, Jill Schriewer, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|August 8, 2015
Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activityAlla Kachko, Sharon E Frey, Lev Sirota, et al.
The Journal of Infectious Diseases|September 20, 2005
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functionsGetahun Abate, Joy Eslick, Frances K Newman, et al.
Vaccine|December 17, 2008
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adultsSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
The Journal of Infectious Diseases|January 28, 2004
Dose-dependent neutralizing-antibody responses to vacciniaRobert B Belshe, Frances K Newman, Sharon E Frey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2013
CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humansLiusong Yin, J Mauricio Calvo-Calle, John Cruz, et al.
Vaccine|February 7, 2022
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderlyGeoffrey J Gorse, Stephen Grimes, Helen Buck, et al.
The Journal of Infectious Diseases|August 4, 2010
Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteinsRanjit Ray, Keith Meyer, Arup Banerjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Evidence for probable sexual transmission of the hepatitis g virusSharon E Frey, Sharon M Homan, Marcia Sokol-Anderson, et al.
Vaccine|February 7, 2022
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery systemGeoffrey J Gorse, Stephen Grimes, Helen Buck, et al.
Vaccine|November 9, 2010
VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response aloneLeonard Moise, R Mark Buller, Jill Schriewer, et al.
Pageof 12